Cargando…
Long noncoding RNAs in prostate cancer: overview and clinical implications
Prostate cancer is the second most common cause of cancer mortality among men in the United States. While many prostate cancers are indolent, an important subset of patients experiences disease recurrence after conventional therapy and progresses to castration-resistant prostate cancer (CRPC), which...
Autores principales: | Malik, Bhavna, Feng, Felix Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955180/ https://www.ncbi.nlm.nih.gov/pubmed/27072044 http://dx.doi.org/10.4103/1008-682X.177123 |
Ejemplares similares
-
Identification and characterization of functional long noncoding RNAs in cancer
por: Olivero, Christiane E., et al.
Publicado: (2020) -
Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo
por: Pestell, Richard G, et al.
Publicado: (2014) -
Prostate cancer epigenetics and its clinical implications
por: Yegnasubramanian, Srinivasan
Publicado: (2016) -
Epigenetic regulation of prostate cancer: the theories and the clinical implications
por: Liao, Yiji, et al.
Publicado: (2019) -
Long noncoding RNA-mediated activation of androgen receptor in prostate cancer
por: Petrovics, Gyorgy, et al.
Publicado: (2014)